Positional variations in mammary gland development and cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 18, Issue 2, 2013, Pages 179-188

  Veltmaat, Jacqueline M ^a   Ramsdell, Ann F ^b,c   Sterneck, Esta ^d  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anterior posterior; Asymmetry; Body axis; Breast cancer; Embryonic development; Mammary gland

Indexed keywords

HOX PROTEIN; WNT PROTEIN;

ANATOMY; BREAST CANCER; CANCER INCIDENCE; CANCER SURVIVAL; CELL FATE; DEVELOPMENT; DISEASE COURSE; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; MAMMARY GLAND; METASTASIS; MORPHOGENESIS; MORPHOLOGY; NONHUMAN; PATHOLOGY; REVIEW; WNT SIGNALING PATHWAY;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL;

EID: 84879685763     PISSN: 10833021     EISSN: 15737039     Source Type: Journal    
DOI: 10.1007/s10911-013-9287-3     Document Type: Review

References (83)

1. Bresslau E. The structure and development of the mammary apparatus in the marsupialia., in The Mammary Apparatus of the Mammalia - in the light of ontogenesis and phylogenesis. London: Methuen and Co. Ltd; 1920. p. 44-95.
2. Propper AY. Wandering epithelial cells in the rabbit embryo milk line. A preliminary scanning electron microscope study. Dev Biol. 1978;67(1):225-31.
3. Veltmaat JM et al. Identification of the mammary line in mouse by Wnt10b expression. Dev Dyn. 2004;229(2):349-56.
4. Propper AY, Howard BA, Veltmaat J.M. Prenatal morphogenesis of mammary glands in mouse and rabbit. J Mammary Gland Biol Neoplasia. 2013. doi: 10.1007/s10911-013-9298-0.
5. Robinson GW, Karpf AB, Kratochwil K. Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia. 1999;4(1):9-19.
6. Gilbert AN. Mammary number and litter size in Rodentia: the "one-half rule". Proc Natl Acad Sci U S A. 1986;83(13):4828-30.
7. Bell A. Bell on the development by selection of supernumerary mammae in sheep. Science. 1899;9(227):637-9.
8. Hsu MJ et al. High incidence of supernumerary nipples and twins in formosan macaques (Macaca cyclopis) at Mt. Longevity, Taiwan. Am J Primatol. 2000;52(4):199-205.
9. Cellini A, Offidani A. Familial supernumerary nipples and breasts. Dermatology. 1992;185(1):56-8.
10. Hirooka H et al. A whole-genome scan for quantitative trait loci affecting teat number in pigs. J Anim Sci. 2001;79(9):2320-6.
11. Kratochwil K. Organ specificity in mesenchymal induction demonstrated in the embryonic development of the mammary gland of the mouse. Dev Biol. 1969;20(1):46-71.
12. Propper A, Gomot L. Tissue interactions during organogenesis of the mammary gland in the rabbit embryo. C R Acad Sci Hebd Seances Acad Sci D. 1967;264(22):2573-5.
13. Lee MY et al. Ectodermal influx and cell hypertrophy provide early growth for all murine mammary rudiments, and are differentially regulated among them by Gli3. PLoS One. 2011;6(10):e26242.
14. Veltmaat JM et al. Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes. Development. 2006;133(12):2325-35.
15. Mailleux AA et al. Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development. 2002;129(1):53-60.
16. Howard B et al. Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification. Genes Dev. 2005;19(17):2078-90.
17. Davenport TG, Jerome-Majewska LA, Papaioannou VE. Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development. 2003;130(10):2263-73.
18. Jerome-Majewska LA et al. Tbx3, the ulnar-mammary syndrome gene, and Tbx2 interact in mammary gland development through a p19Arf/p53-independent pathway. Dev Dyn. 2005;234(4):922-33.
19. Shermak MA. Congenital and developmental abnormalities of the breast, in Management of Breast Diseases, Jatoi I, Kaufman M, editors. 2010, Springer. p. 37-51.
20. Schmidt H. Supernumerary nipples: prevalence, size, sex and side predilection - a prospective clinical study. Eur J Pediatr. 1998;157(10):821-3.
21. Little CC, McDonald H. Abnormalities of the mammae in the house mouse. J Hered. 1945;36:285-8.
22. Shiratori H, Hamada H. The left-right axis in the mouse: from origin to morphology. Development. 2006;133(11):2095-104.
23. Ramsdell AF. Left-right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left-right axis determination. Dev Biol. 2005;288(1):1-20.
24. Golding JP et al. Mouse myotomes pairs exhibit left-right asymmetric expression of MLC3F and alpha-skeletal actin. Dev Dyn. 2004;231(4):795-800.
25. Golding JP et al. Heparin-binding EGF-like growth factor shows transient left-right asymmetrical expression in mouse myotome pairs. Gene Expr Patterns. 2004;5(1):3-9.
26. Kawakami Y et al. Retinoic acid signalling links left-right asymmetric patterning and bilaterally symmetric somitogenesis in the zebrafish embryo. Nature. 2005;435(7039):165-71.
27. Vermot J, Pourquie O. Retinoic acid coordinates somitogenesis and left-right patterning in vertebrate embryos. Nature. 2005;435(7039):215-20.
28. Cho KW et al. Retinoic acid signaling and the initiation of mammary gland development. Dev Biol. 2012;365(1):259-66.
29. Vermot J et al. Retinoic acid controls the bilateral symmetry of somite formation in the mouse embryo. Science. 2005;308(5721):563-6.
30. Blot W, Fraumeni J, Young J. Left-sided breast cancer. Lancet. 1977;2:762-3.
31. Ekbom A et al. Epidemiologic correlates of breast cancer laterality. Cancer Causes Control. 1994;7:539-43.
32. Garinkel L, Craig L, Seidman H. An appraisal of left and right breast cancer. J Natl Cancer Inst. 1959;23:617-31.
33. Roychoudhuri R, Putcha V, Møller H. Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes and Control. 2006;17(5):655-62.
34. Tulinius H et al. Tumors in Iceland: 10. Malignant tumours of the breast. A histological classification, laterlaity, survival and epidemiological considerations. Acta path Microbiol Immunol Scand. 1988;96:229-38.
35. Weiss H, Devesa S, Brinton L. Laterality of breast cancer. Cancer Causes Control. 1996;7:539-43.
36. Fatima N et al. Lower incidence but more aggressive behavior of right sided breast cancer in pakistani women: does right deserve more respect? Asian Pac J Cancer Prev. 2013;14(1):43-5.
37. Senie R et al. Epidemiology of breast carcinoma II: factors related to the predominance of left-sided disease. Cancer Causes and Control. 1980;46:1705-13.
38. Borisenkov MF and Bazhenov SM. Survival in human breast cancer: effects of tumor laterality and the time of year of surgery. Human Physiology. 2001;27(5):631-34.
39. Hartveit F, Tangen M, Hartveit E. Side and survival in breast cancer. Oncology. 1984;41(3):149-54.
40. Melnik Y et al. Breast cancer in Israel: laterality and survival. J Cancer Res Clin Oncol. 1979;95(3):291-3.
41. Delahunt B, Bethwaite P, Nacey JN. Renal cell carcinoma in New Zealand: a national survival study. Urology. 1994;43(3):300-9.
42. Pece S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. cell. 140(1): 62-73.
43. Cappello F et al. Study of axillary lymph node asymmetry in a female population. J Anat. 2001;199(Pt 5):617-20.
44. Dane S et al. Asymmetries in breast cancer lateralization and both axillary lymph node number and metastatic involvement. Lymphology. 2008;41(2):75-9.
45. Nouh MA et al. Lymph node metastasis in breast carcinoma: clinicopathological correlations in 3747 patients. J Egypt Natl Canc Inst. 2004;16(1):50-6.
46. Saleh F, Abdeen S. Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis. J Carcinog. 2007;6:12.
47. Wilting J, Hagedorn M. Left-right asymmetry in embryonic development and breast cancer: common molecular determinants? Curr Med Chem. 2011;18(36):5519-27.
48. Kenney NJ, Adkins HB, Sanicola M. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia. 2004;9(2):133-44.
49. Strizzi L et al. Emerging roles of nodal and cripto-1: from embryogenesis to breast cancer progression. Breast Dis. 2008;29(-1):91-103.
50. Harbeck N et al. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol. 2008;26(31):5036-42.
51. Quail DF et al. Nodal signalling in embryogenesis and tumourigenesis. Int J Biochem Cell Biol. 2013;45(4):885-98.
52. Vaage J. Relationship between tumor growth characteristics and preferential sites of growth. J Natl Cancer Inst. 1984;72(5):1199-203.
53. Russo IH, Russo J. Hormone prevention of mammary carcinogenesis: a new approach in anticancer research. Anticancer Res. 1988;8(6 489011536):1247-64.
54. Ball SM. The development of the terminal end bud in the prepubertal-pubertal mouse mammary gland. Anat Rec. 1998;250(4):459-64. 397175680.
55. Mevissen M, Haussler M, Loscher W. Alterations in ornithine decarboxylase activity in the rat mammary gland after different periods of 50 Hz magnetic field exposure. Bioelectromagnetics. 1999;20(6):338-46.
56. Fedrowitz M, Loscher W. Exposure of Fischer 344 rats to a weak power frequency magnetic field facilitates mammary tumorigenesis in the DMBA model of breast cancer. Carcinogenesis. 2008;29(1):186-93.
57. Davie SA et al. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 2007;16(2):193-201.
58. Guy CT et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A. 1992;89(22):10578-82.
59. Green JE et al. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Res. 2001;61(20):7449-55.
60. Varticovski L et al. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res. 2007;13(7):2168-77.
61. Oosterhuis JW et al. The effects of regional factors on the growth rate and the differentiation of mouse teratocarcinoma. Br J Cancer. 1983;47(3):407-11. 708612944.
62. Meschter CL, Connolly JM, Rose DP. Influence of regional location of the inoculation site and dietary fat on the pathology of MDA-MB-435 human breast cancer cell-derived tumors grown in nude mice. Clin Exp Metastasis. 1992;10(3 982934656):167-73.
63. Sheldon WG et al. Distribution of mammary gland neoplasms and factors influencing metastases in hybrid mice. Lab Anim Sci. 1982;32(2):166-8.
64. Auerbach R, Auerbach W. Regional differences in the growth of normal and neoplastic cells. Science. 1982;215(4529):127-34.
65. Minasian H, Minassian D. The relationship between blood flow of mammary tissue and its overlying skin in the mouse. Lab Anim. 1983;17(4):321-3.
66. Takebe N, Warren RQ, Ivy SP. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res. 2011;13(3):211.
67. Rinn JL et al. A dermal HOX transcriptional program regulates site-specific epidermal fate. Genes Dev. 2008;22(3):303-7.
68. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10(5):361-71.
69. Aulehla A, Pourquie O. Signaling gradients during paraxial mesoderm development. Cold Spring Harb Perspect Biol. 2010;2(2):a000869.
70. Bondos S. Variations on a theme: Hox and Wnt combinatorial regulation during animal development. Sci STKE. 2006;2006(355):pe38.
71. Garcia-Gasca A, Spyropoulos DD. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Dev Dyn. 2000;219(2):261-76.
72. Hatsell SJ, Cowin P. Gli3-mediated repression of Hedgehog targets is required for normal mammary development. Development. 2006;133(18):3661-70.
73. Yang A et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398(6729):714-8.
74. Mills AA et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999;398(6729):708-13.
75. Asselin-Labat ML et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol. 2007;9(2):201-9.
76. Chu EY, et al. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development. 2004; 131(19): 4819-29.
77. Boras-Granic K et al. Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland. Dev Biol. 2006;295(1):219-31.
78. Gu B et al. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J Cell Biol. 2009;185(5):811-26.
79. Lindvall C et al. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem. 2006;281(46):35081-7.
80. Lindvall C et al. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS One. 2009;4(6):e5813.
81. Ahn Y et al. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling. Development. 2013;140(3):583-93.
82. Mustonen T et al. Ectodysplasin A1 promotes placodal cell fate during early morphogenesis of ectodermal appendages. Development. 2004;131(20):4907-19.
83. Narhi K et al. Sostdc1 defines the size and number of skin appendage placodes. Dev Biol. 2012;364(2):149-61.